Solutions
Empower Patent Analytics
Empower Litigation Defense
Empower License Manager
Use Cases
Patent Licensing
Portfolio Management
Litigation Strategy
Market Intelligence
Data Platform
Contact Us
Login
×
View as Organization
Mylan Pharmaceuticals Incorporated et al v. UCB Pharma GmbH IPR of '772
PTAB
CAFC
IPR2016-00517
1600
Judge
: Kristina M. Kalan
+5
Filed
:
01/28/2016
Institution
: 07/20/2016
Final Decision
: 09/29/2017
Latest Docket Entry
: 09/29/2017
PTAB
Administrative Judges
Kristina M. Kalan
Michelle N. Ankenbrand
Rama G. Elluru
Robert A. Pollock
Alert
Pin
2
Petitioners
1
Patent Owner
1
Challenged Patent
Overview
Docket (260 Entries)
Campaign
Claims Analytics
Mylan Pharmaceuticals Incorporated et al v. UCB Pharma GmbH IPR of '772
PTAB
CAFC
IPR2016-00517
1600
Judge
: Kristina M. Kalan
+5
Filed
:
01/28/2016
Institution
: 07/20/2016
Final Decision
: 09/29/2017
Latest Docket Entry
: 09/29/2017
PTAB
Administrative Judges
Kristina M. Kalan
Michelle N. Ankenbrand
Rama G. Elluru
Robert A. Pollock
Alert
Pin
Overview
Docket (260 Entries)
Campaign
Claims Analytics
Overview
Docket (260 Entries)
Campaign
Claims Analytics
View Petition
Appeals
17-2531
17-2586
Final Decision
No Claims Unpatentable
Cause of Action
Inter Partes Review
Administrative Judges
Kristina M. Kalan
Michelle N. Ankenbrand
Rama G. Elluru
Robert A. Pollock
Patent Information
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
Related Petitions
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
2
Petitioners
This parent entity is not a named party
Pfizer Inc.
Mylan Laboratories Limited
Analyze
Counsel Representation
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
Mylan Pharmaceuticals Incorporated
Analyze
Counsel Representation
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
1
Patent Owner
This parent entity is not a named party
UCB SA
UCB Pharma GmbH
Analyze
Counsel Representation
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
2
Petitioner RPIs
This parent entity is not a named party
Pfizer Inc.
Mylan Laboratories Limited
Analyze
Counsel Representation
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
Mylan N.V.
Analyze
Counsel Representation
Subscription Required
This content requires a subscription to view
Contact Us
or
Login
×
×